MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CERS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Cerus (CERS) Ownership - Who owns Cerus?

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Medical Specialties
Address
1220 Concord Avenue
Phone
+1 925 288-6000
Employees
275
Web
https://www.cerus.com

Details

Group
Domestic Stock Funds
Category
Health Services
Capitalization
529.98M
P/E Ratio
N/A
Total Cash
80.43M
Projected Growth
N/A
Total Debt
97.36M
Revenue
216.56M
Risk (Beta)
2.86
Dividend Yield
N/A
Total Cash/Share
0.40
Total Debt/Equity
7.28
Revenue/Share
1.13 USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CERS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for CERS
A.I. Advisor
published General Information

General Information

a developer of the INTERCEPT Blood System for platelets and plasma

Industry MedicalNursingServices

Profile
Details
Industry
Medical Specialties
Address
1220 Concord Avenue
Phone
+1 925 288-6000
Employees
275
Web
https://www.cerus.com